UnknownPhase 3NCT01652118

Clarithromycin Prophylaxis in Preterm Infants Colonisation With Ureaplasma Urealyticum and Mycoplasma Hominis

Studying Bronchopulmonary dysplasia

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Zekai Tahir Burak Women's Health Research and Education Hospital
Principal Investigator
Ugur Dilmen, Prof. Dr.
Zekai Tahir Burak Women's Health Research and Education Hospital
Intervention
clarithromycin treatment for prophylaxis of bronchopulmonary dysplasia(drug)
Enrollment
250 enrolled
Eligibility
All sexes
Timeline
2011 – 2013

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01652118 on ClinicalTrials.gov

Other trials for Bronchopulmonary dysplasia

Additional recruiting or active studies for the same condition.

See all trials for Bronchopulmonary dysplasia →

← Back to all trials